Form 4 for WGS GeneDx Holdings Corp.
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-29 · accession 0001415889-24-020434 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-31 | 2024-07-29 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 94.7K | +4% | $0 |
| D | 2024-07-31 | 2024-07-29 | WGS | Stueland Katherine | CEO, Dir | S - Sale+OE | $33.54 | -2,154 | 92.5K | -2% | -$72.2K |
| D | 2024-07-31 | 2024-07-29 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | -3,874 | 27.1K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-07-29 | M | A | 3,874 | $0.00 | 94,704 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Common | Class A Common Stock | 2024-07-29 | S | D | 2,154 | $33.54 | 92,550 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-07-29 | M | D | 3,874 | $0.00 | 27,118 | D | — · — to — | 3,874 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 25% of the underlying shares each vested on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |